Forbion

Forbion is a leading global venture capital firm with deep expertise in Europe. We invest in innovative biotech companies, managing just over €5 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. In addition, we leverage our biotech expertise beyond human health to address ‘planetary health’ challenges through our BioEconomy fund strategy, which invests in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies. We select impactful investments that will positively affect the health and well-being of people and the planet, as well as meet its financial return objectives Forbion has offices in Naarden, The Netherlands, Munich, Germany, and Boston, USA.